Voya Investment Management LLC Has $71,000 Holdings in OraSure Technologies, Inc. $OSUR

Voya Investment Management LLC cut its position in shares of OraSure Technologies, Inc. (NASDAQ:OSUR) by 16.9% in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 21,006 shares of the medical instruments supplier’s stock after selling 4,261 shares during the quarter. Voya Investment Management LLC’s holdings in OraSure Technologies were worth $71,000 at the end of the most recent reporting period.

Several other large investors also recently modified their holdings of OSUR. Ameriprise Financial Inc. increased its position in shares of OraSure Technologies by 65.1% during the fourth quarter. Ameriprise Financial Inc. now owns 173,989 shares of the medical instruments supplier’s stock worth $628,000 after buying an additional 68,629 shares during the period. ProShare Advisors LLC increased its position in shares of OraSure Technologies by 49.0% during the fourth quarter. ProShare Advisors LLC now owns 20,327 shares of the medical instruments supplier’s stock worth $73,000 after buying an additional 6,689 shares during the period. Two Sigma Investments LP acquired a new stake in shares of OraSure Technologies during the fourth quarter worth $552,000. Two Sigma Advisers LP increased its position in shares of OraSure Technologies by 36.9% during the fourth quarter. Two Sigma Advisers LP now owns 97,200 shares of the medical instruments supplier’s stock worth $351,000 after buying an additional 26,200 shares during the period. Finally, Public Employees Retirement System of Ohio acquired a new stake in shares of OraSure Technologies during the fourth quarter worth $277,000. 93.50% of the stock is currently owned by institutional investors and hedge funds.

OraSure Technologies Stock Down 1.9%

Shares of NASDAQ OSUR opened at $3.15 on Thursday. The firm has a market cap of $230.39 million, a PE ratio of -4.70 and a beta of 0.46. OraSure Technologies, Inc. has a 12-month low of $2.36 and a 12-month high of $4.60. The company’s fifty day simple moving average is $3.14 and its 200 day simple moving average is $3.05.

OraSure Technologies Profile

OraSure Technologies, Inc, together with its subsidiaries, provides point-of-care and home diagnostic tests, specimen collection devices, and microbiome laboratory and analytical services in the United States, Europe, and internationally. The company’s products include InteliSwab COVID-19 rapid test, InteliSwab COVID-19 rapid test pro, InteliSwab COVID-19 rapid test rx, OraQuick Rapid HIV test, OraQuick In-Home HIV test, OraQuick HIV self-test, OraQuick HCV rapid antibody test, OraQuick Ebola rapid antigen test, OraSure oral fluid collection device used in conjunction with screening and confirmatory tests for HIV-1 antibodies; Intercept drug testing systems; immunoassay tests and reagents; and Q.E.D.